Skip to content

Expanded Access for Anti-IL8

Status
NO_LONGER_AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT05210894
Enrollment
Unknown
Registered
2022-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This is an expanded access designed to provide access to Anti-IL8 for eligible participants.

Interventions

BIOLOGICALAnti-IL8

Sponsors

Bristol-Myers Squibb
Lead SponsorINDUSTRY

Eligibility

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026